Abstract |
TNF-alpha is an essential component of the innate defence mechanism of the host against pathogenic challenge. Unfortunately, it can also play a major role in the pathology of certain diseases, such as tuberculosis. This disease is a striking example of the role of TNF-alpha as a 'double-edged sword', because apart from its role in controlling the Mycobacterium tuberculosis infection, it can also cause severe tissue damage. TNF-alpha exhibits a very complex network of interactions and many of its activities are still not fully understood. This report aims to review the pivotal role of TNF-alpha in controlling the mycobacterial infection, with a particular emphasis on its influence on chemokine expression and cell movement during granuloma formation, and the issues surrounding the use of TNF-alpha inhibitors for therapeutic use in inflammatory diseases.
|
Authors | Amanda Mootoo, Elena Stylianou, Mauricio A Arias, Rajko Reljic |
Journal | Inflammation & allergy drug targets
(Inflamm Allergy Drug Targets)
Vol. 8
Issue 1
Pg. 53-62
(Mar 2009)
ISSN: 2212-4055 [Electronic] United Arab Emirates |
PMID | 19275693
(Publication Type: Journal Article, Review)
|
Chemical References |
- Receptors, Tumor Necrosis Factor
- Tumor Necrosis Factor-alpha
|
Topics |
- Animals
- Apoptosis
- Cell Differentiation
- Dendritic Cells
(immunology, metabolism, pathology)
- Granuloma
(immunology)
- Humans
- Immunity, Cellular
- Immunity, Innate
- Inflammation
- Macrophages
(immunology, metabolism, microbiology, pathology)
- Mycobacterium tuberculosis
(immunology)
- Receptors, Tumor Necrosis Factor
(genetics, immunology, metabolism)
- Th1 Cells
(immunology, metabolism)
- Tuberculosis, Pulmonary
(immunology, metabolism, pathology)
- Tumor Necrosis Factor-alpha
(genetics, immunology, metabolism)
|